The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact
Abstract
PURPOSE OF REVIEW: This review discusses the recent findings (July 2008-January 2010) on extended-spectrum [beta]-lactamase (ESBL)-producing Escherichia coli, mainly focussed on the epidemiology and clinical impact of infections owing to this pathogen. RECENT FINDINGS: CTX-M-producing E. coli, mainly the CTX-M-15 producers, has emerged and disseminated worldwide as an important cause of both nosocomial and community-onset infections. The clonal spread of the ST131 epidemic E. coli strain is linked not only to the CTX-M-15 pandemia but also to other ESBLs types. The most commonly reported risk factors for community-onset ESBL-producing E. coli infections are contact with healthcare centres, recent use of antimicrobial agents, and presence of comorbidities. But infections owing to ESBL-producing E. coli in patients without obvious risk factors can occur, probably related to the increase of healthy carriers colonized with this pathogen. The main significant predictor of mortality caused by ESBL-producing E. coli is inadequate initial antimicrobial therapy. Alternatives of treatment of severe ESBL-producing E. coli infections included carbapenems, amikacin, tigecycline, and [beta]-lactam/[beta]-lactamase inhibitor combinations; with some of them enough clinical evidence is lacking (tigecycline, [beta]-lactam/[beta]-lactamase inhibitor combinations). For urinary tract infections, fosfomycin and nitrofurantoin could be useful. SUMMARY: The worldwide emergence of multiresistant ESBL-producing E. coli raises key therapeutic problems; interventions addressed to their quick detection and early appropriate antibiotic treatment and prevention are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
Coque, T. M., Baquero, F., & Cantón, R. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19044-en · Cited by 799
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M., & Karageorgopoulos, D. E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70325-1 · Cited by 487
Ben‐Ami, R., Rodríguez‐Baño, J., Arslan, H., Pitout, J. D. D., Quentin, C., Calbo, E. S., Azap, Ö. K., Arpin, C., Pascual, A., Livermore, D. M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604713 · Cited by 462
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Rodríguez-Baño, J., Alcalá, J. C., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tórtola, T., Mirelis, B., Navarro, G., Cuenca, M., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.17.1897 · Cited by 379
Rodríguez‐Baño, J., Picón, E., Gijón, P., Hernández, J. R., Ruíz, M., Peña, C., Almela, M., Almirante, B., Grill, F., Colomina, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649537 · Cited by 347
Woodford, N., Carattoli, A., Karisik, E., Underwood, A., Ellington, M. J., & Livermore, D. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00688-09 · Cited by 283
Bonnedahl, J., Drobni, M., Gauthier-Clerc, M., Hernandez, J., Granholm, S., Kayser, Y., Melhus, Å., Kahlmeter, G., Waldenström, J., Johansson, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005958 · Cited by 252
Laupland, K. B., Church, D. L., Vidakovich, J., Mucenski, M., & Pitout, J. D. D. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.09.034 · Cited by 238
Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P.-R., & Paterson, D. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-09 · Cited by 224
Defining an extended-spectrum β-lactamase
Livermore, D. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01857.x · Cited by 222
Rodriguez-Bano, J., Lopez-Cerero, L., Navarro, M. D., de Alba, P. D., & Pascual, A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn293 · Cited by 212
Ortega, M., Marco, F., Soriano, A., Almela, M., Martínez, J. A., Muñoz, A., & Mensa, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn514 · Cited by 211
Oteo, J., Navarro, C., Cercenado, E., Delgado-Iribarren, A., Wilhelmi, I., Orden, B., García, C., Miguelañez, S., Pérez-Vázquez, M., García-Cobos, S., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00447-06 · Cited by 202
Self-citationRooney, P. J., O'Leary, M. C., Loughrey, A. C., McCalmont, M., Smyth, B., Donaghy, P., Badri, M., Woodford, N., Karisik, E., & Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp220 · Cited by 198
Trecarichi, E. M., Tumbarello, M., Spanu, T., Caira, M., Fianchi, L., Chiusolo, P., Fadda, G., Leone, G., Cauda, R., & Pagano, L. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.02.002 · Cited by 194
Kelesidis, T., Karageorgopoulos, D. E., Kelesidis, I., & Falagas, M. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn311 · Cited by 186
Azap, Ö. K., Arslan, H., Şerefhanoğlu, K., Çolakoğlu, Ş., Erdoğan, H., Timurkaynak, F., & Senger, S. S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02941.x · Cited by 180
Suzuki, S., Shibata, N., Yamane, K., Wachino, J.-I., Ito, K., & Arakawa, Y. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn463 · Cited by 178
Oteo, J., Diestra, K., Juan, C., Bautista, V., Novais, Â., Pérez-Vázquez, M., Moyá, B., Miró, E., Coque, T. M., Oliver, A., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.03.006 · Cited by 173
Self-citationLau, S. H., Kaufmann, M. E., Livermore, D. M., Woodford, N., Willshaw, G. A., Cheasty, T., Stamper, K., Reddy, S., Cheesbrough, J., Bolton, F. J., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn380 · Cited by 163
Costa, D., Vinué, L., Poeta, P. A. C. Q. D., Coelho, A. C., Matos, M., Sáenz, Y., Somalo, S., Zarazaga, M., Rodrigues, J., & Torres, C. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.03.029 · Cited by 148
Sidjabat, H. E., Paterson, D. L., Adams‐Haduch, J. M., Ewan, L., Pasculle, A. W., Muto, C. A., Tian, G., & Doi, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00533-09 · Cited by 146
Pitout, J. D. D., Gregson, D. B., Campbell, L., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-09 · Cited by 145
Arpin, C., Quentin, C., Grobost, F., Cambau, E., Robert, J., Dubois, V., Coulange, L., & André, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp108 · Cited by 137
Tumbarello, M., Sali, M., Trecarichi, E. M., Leone, F., Rossi, M., Fiori, B., PASCALE, G. D., D’Inzeo, T., Sanguinetti, M., Fadda, G., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00063-08 · Cited by 136
Blanco, M., Alonso, M. P., Nicolas-Chanoine, M.-H., Dahbi, G., Mora, A., Blanco, J. E., López, C., Cortés, P., Llagostera, M., Leflon‐Guibout, V., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp122 · Cited by 126
Emergence of imipenem resistance in clinical Escherichia coli during therapy
Oteo, J., Delgado‐Iribarren, A., Vega, D., Bautista, V., Rodríguez, M. C., Velasco, M., Saavedra, J. M., Pérez-Vázquez, M. D., García-Cobos, S., Martínez-Martínez, L., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.012 · Cited by 117
Self-citationPeirano, G., Richardson, D. C., Nigrin, J., McGeer, A., Loo, V. G., Toye, B., Alfa, M. J., Pienaar, C., Kibsey, P., & Pitout, J. D. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01338-09 · Cited by 113
Sasaki, T., Hirai, I., Niki, M., Nakamura, T., Komalamisra, C., Maipanich, W., Kusolsuk, T., Sanguankiat, S., Pubampen, S., & Yamamoto, Y. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq008 · Cited by 107
Poeta, P. A. C. Q. D., Radhouani, H., Pinto, L., Martinho, A., Rego, V., Rodrigues, R., Gonçalves, A., Rodrigues, J., Estepa, V., Torres, C., et al. (2009) · Journal of Basic Microbiology · doi:10.1002/jobm.200900066 · Cited by 101
Dominance of bla CTX-M within an Australian Extended-Spectrum β-Lactamase Gene Pool
Zong, Z., Partridge, S. R., Thomas, L. C., & Iredell, J. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00107-08 · Cited by 101
Oteo, J., Orden, B., Bautista, V., Cuevas, Ó., Arroyo, M., Martínez-Ruiz, R., Pérez-Vázquez, M. D., Alcaraz, M., García-Cobos, S., & Campos, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp288 · Cited by 99
Self-citationVinué, L., Sáenz, Y., Martínez‐Lumbreras, S., Somalo, S., Moreno, M. Á., Torres, C., & Zarazaga, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02803.x · Cited by 96
Song, K., Jeon, J. H., Park, W. B., Park, S., Kim, H. B., Oh, M., Lee, H.-S., Kim, N. J., & Choe, K. W. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-41 · Cited by 87
Naseer, U., Haldorsen, B. C., Tofteland, S., Hegstad, K., Scheutz, F., Simonsen, G. S., Sundsfjord, A., & THE NORWEGIAN ESBL STUDY GROUP (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02465.x · Cited by 84
Slama, K. B., Jouini, A., Sallem, R. B., Somalo, S., Sáenz, Y., Estepa, V., Boudabous, A., & Torres, C. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2009.12.003 · Cited by 78
Vigil, K. J., Johnson, J. R., Johnston, B., Kontoyiannis, D. P., Mulanovich, V. E., RAAD, I. I., DuPont, H. L., & Adachi, J. A. (2009) · Clinical Infectious Diseases · doi:10.1086/649866 · Cited by 73
Liu, W. Y., Chen, L., Haoyang, L. I., Duan, H., Zhang, Y., Liang, X., Li, X., Zou, M., Xu, L., & Hawkey, P. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp068 · Cited by 70
Tian, S., Chen, B. Y., Chu, Y. Z., & Wang, S. (2008) · Canadian Journal of Microbiology · doi:10.1139/w08-059 · Cited by 69
Hawser, S., Bouchillon, S. K., Hoban, D. J., & Badal, R. E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.07.013 · Cited by 67
Extended-spectrum β-lactamases in ambulatory care: a clinical perspective
Rodríguez‐Baño, J., Navarro, M. D., & Ngugro, M. D. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01866.x · Cited by 64
Freeman, J. T., McBride, S., Heffernan, H., Bathgate, T., Pope, C., & Ellis-Pegler, R. B. (2008) · Clinical Infectious Diseases · doi:10.1086/590941 · Cited by 57
Hanson, N. D., Moland, E. S., Chong, Y., Propst, K. L., Novak, D. J., & Cavalieri, S. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00877-08 · Cited by 44
Guimarães, B., Barreto, Â., Radhouani, H., Figueiredo, N., Gaspar, E., Rodrigues, J., Torres, C., Igrejas, G., & Poeta, P. A. C. Q. D. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0910 · Cited by 43
Prevalence of CTX-M β-Lactamases in Philadelphia, Pennsylvania
McGettigan, S. E., Hu, B., Andreacchio, K., Nachamkin, I., & Edelstein, P. H. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-09 · Cited by 41
Rodríguez‐Baño, J., Alcalá, J., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tórtola, T., Mirelis, B., Navarro, G., Cuenca, M., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp028 · Cited by 30
Lee, C. I., Lee, N. Y., Yan, J. J., Lee, H. C., Ko, N., Chang, C., Wu, C. J., Chen, P. L., Wang, L. R., & Ko, W. (2009) · PubMed · Cited by 15
Cited by
Llor, C., & Bjerrum, L. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614554919 · Cited by 2,079
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Agriculture and food animals as a source of antimicrobial-resistant bacteria
Economou, V., & Gousia, P. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s55778 · Cited by 761
Fishman, N., Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, & Pediatric Infectious Diseases Society (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/665010 · Cited by 677
Metadata
- Authors
- Oteo, J., Pérez-Vázquez, M., & Campos, J.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2010-08
- Volume
- 23
- Issue
- 4
- Pages
- 320-326
- ISSN
- 0951-7375 (ISSN-L)
- OpenAlex
- W1975477890
- Cited by
- 284
- References
- 50
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.